Circulating hepatocyte growth factor levels in multiple myeloma

Incidence and Factors Associated with Graft-Versus-Host Disease in the First Year After Allogeneic Peripheral Blood Stem Cell Transplantation.

Journal of immunotherapy and precision oncology·2025

Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.

British journal of haematology·2021

Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group.

The Lancet. Oncology·2021

ACT-FASTER, a Prospective Cohort Study Exploring Treatment Patterns with Fulvestrant and Exemestane in Postmenopausal Patients with Advanced Hormone Receptor-Positive Breast Cancer under Real-Life Conditions in Germany.

Breast care (Basel, Switzerland)·2020

Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis.

Leukemia·2019

Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells.

Anticancer research·2018

Immune features of graft-derived mucosal-associated invariant T cells predict gastrointestinal graft-versus-host disease.

British journal of haematology·2026

Venetoclax-enhanced reduced-intensity conditioning in older patients aged ≥55 years with high-risk myeloid malignancies undergoing allogeneic peripheral blood stem cell transplantation: A phase II study.

British journal of haematology·2026

Socioeconomic inequality in treatment of acute myeloid leukaemia (AML) in England, 2015-2022: A population-based study.

British journal of haematology·2026

Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study.

British journal of haematology·2026

Red lines and green lights: Gene therapy for inherited erythroid disorders beyond the haemoglobinopathies.

British journal of haematology·2026

Targeting nuclear export and Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) signalling in myelofibrosis: A novel combinatorial strategy that impacts intrinsic and microenvironment-related pathways.

British journal of haematology·2026

Melasma Flaring and Unmasking After Treatment With a 1,927-nm Non-ablative Fractional Thulium Fiber Laser.

Cureus·2026

From Dermographism in Bracelets to Dermatophytosis in Circles: The First Case of Tinea Imbricata Diagnosed in Morocco.

Cureus·2026

Analytical validation of a multiplex PCR assay for differentiation of five clinically significant nontuberculous mycobacterial species.

Frontiers in microbiology·2026

Treatment patterns and outcomes in patients with multiple myeloma in second relapse in Colombia (freedomm): a multicenter observational study.

Frontiers in oncology·2026

Mesenteric defect closure versus non-closure after complete mesocolic excision in minimally invasive right colectomy: a retrospective study.

International journal of colorectal disease·2026

Applying the Moving Epidemic Method to Emergency Department Syndromic Surveillance to identify the Start of Influenza Seasons in New South Wales, Australia.

Influenza and other respiratory viruses·2026

Related Experiment Videos

Circulating hepatocyte growth factor levels in multiple myeloma

Related Concept Videos

Incidence and Factors Associated with Graft-Versus-Host Disease in the First Year After Allogeneic Peripheral Blood Stem Cell Transplantation.

Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.

Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group.

ACT-FASTER, a Prospective Cohort Study Exploring Treatment Patterns with Fulvestrant and Exemestane in Postmenopausal Patients with Advanced Hormone Receptor-Positive Breast Cancer under Real-Life Conditions in Germany.

Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis.

Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells.

Immune features of graft-derived mucosal-associated invariant T cells predict gastrointestinal graft-versus-host disease.

Venetoclax-enhanced reduced-intensity conditioning in older patients aged ≥55 years with high-risk myeloid malignancies undergoing allogeneic peripheral blood stem cell transplantation: A phase II study.

Socioeconomic inequality in treatment of acute myeloid leukaemia (AML) in England, 2015-2022: A population-based study.

Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study.

Red lines and green lights: Gene therapy for inherited erythroid disorders beyond the haemoglobinopathies.

Targeting nuclear export and Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) signalling in myelofibrosis: A novel combinatorial strategy that impacts intrinsic and microenvironment-related pathways.

Melasma Flaring and Unmasking After Treatment With a 1,927-nm Non-ablative Fractional Thulium Fiber Laser.

From Dermographism in Bracelets to Dermatophytosis in Circles: The First Case of Tinea Imbricata Diagnosed in Morocco.

Analytical validation of a multiplex PCR assay for differentiation of five clinically significant nontuberculous mycobacterial species.

Treatment patterns and outcomes in patients with multiple myeloma in second relapse in Colombia (freedomm): a multicenter observational study.

Mesenteric defect closure versus non-closure after complete mesocolic excision in minimally invasive right colectomy: a retrospective study.

Applying the Moving Epidemic Method to Emergency Department Syndromic Surveillance to identify the Start of Influenza Seasons in New South Wales, Australia.

Related Experiment Videos

Circulating hepatocyte growth factor levels in multiple myeloma

Related Concept Videos

Related Articles